UCB To Acquire Candid Therapeutics For Up To $2.2 Bln To Boost Immunology Pipeline NASDAQ · Markets 57m ago
Endeavour Group Q3 Total Sales Up, Sees Addl. Fuel Charges, A$100 Mln Cost Savings; Stock Down NASDAQ · Markets 1h ago